Business Wire

1. Seek Labs Expands Global Disease Atlas With Mapping Of Hemorrhagic Fever Viruses Through BioSeeker 10/21/2025

   Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas to include multiple hemorrhagic fever viruses. BioSeeker, the company’s AI-powered discovery engine, has completed comprehensive genomic mapping across a suite of high-priority hemorrhagic fever viruses (HFV), which include Ebola virus, Marburg virus, Lassa Virus, Hanta Virus, Crimean-Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV).

2. GeneDx Granted FDA Breakthrough Device Designation For Its ExomeDx And GenomeDx Testing 10/20/2025

   GeneDx a leader in delivering improved health outcomes through genomic insights, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its whole genome and exome tests associated with causes of life-threatening diseases or genetic disorders to aid in diagnosis of symptomatic patients.

3. Augurex Announces Expansion Of Availability Of The JOINTstat Diagnostic Test For Rheumatoid Arthritis With MitogenDx 10/15/2025

   Augurex Life Sciences Corp., a leader in autoimmune-based diagnostics, today announced an agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic testing.

4. Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging The Gap Between PCR And Next-Generation Sequencing Technologies 10/7/2025

   Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing.

5. Revvity Announces Program To Revolutionize The Early Detection Of Type 1 Diabetes 10/2/2025

   Revvity, Inc. today announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi.

6. Quantabio Advances Newborn Screening And Emerging Applications By Streamlining DNA Extraction From Dried Blood Spot Samples 9/30/2025

   Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the launch of the sparQ Lysis Kit.

7. Thermo Fisher Scientific Showcases The Thermo Fisher Connect Platform At Lab Of The Future Europe 9/30/2025

   Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company’s Thermo Fisher Connect Platform can integrate and future-proof laboratories.

8. Agilent Introduces The Altura Line Of Inert HPLC Columns For Superior Results In Biotherapeutic Testing 9/29/2025

   Agilent Technologies Inc. today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications.

9. StatLab Leads Pathology Innovation With U.S. Diapath Equipment Launch 9/26/2025

   StatLab Medical Products, a leading developer and manufacturer of pathology supplies and equipment, today announced the U.S. commercial launch of Diapath signature Pathology instruments.

10. New Research Reinforces C2N's PrecivityAD2 Blood Test As A Highly Accurate Tool To Detect Brain Amyloid Pathology In Symptomatic Patients 9/25/2025

    C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation, is highlighting a peer-reviewed study that independently validates the performance of the PrecivityAD2 blood test among individuals with mild cognitive impairment or dementia.